MedPath

iFreeETF US Treasury Bond 7-10 Year Hdg

🇺🇸United States
Ownership
-
Established
2016-01-01
Employees
-
Market Cap
-
Website
www.grail.com

Clinical Trials

8

Active:4
Completed:1

Trial Phases

1 Phases

Not Applicable:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Not Applicable
4 (100.0%)

The Galleri® Community Research Program

Conditions
Data Collection
First Posted Date
2024-09-19
Last Posted Date
2024-09-19
Lead Sponsor
GRAIL, Inc.
Target Recruit Count
250
Registration Number
NCT06603259
Locations
🇺🇸

GRAIL, Menlo Park, California, United States

Galleri in the Medicare Population

Not Applicable
Recruiting
Conditions
Cancer
First Posted Date
2023-01-05
Last Posted Date
2025-06-26
Lead Sponsor
GRAIL, Inc.
Target Recruit Count
50000
Registration Number
NCT05673018
Locations
🇺🇸

Geisinger Bloomsburg Hospital, Bloomsburg, Pennsylvania, United States

🇺🇸

HCA Healthcare Brentwood, Brentwood, Tennessee, United States

🇺🇸

HCA Healthcare Centennial, Nashville, Tennessee, United States

and more 33 locations

Does Screening with the Galleri Test in the NHS Reduce the Likelihood of a Late-stage Cancer Diagnosis in an Asymptomatic Population? a Randomised Clinical Trial

Not Applicable
Active, not recruiting
Conditions
Cancer
First Posted Date
2022-11-10
Last Posted Date
2025-02-14
Lead Sponsor
GRAIL, Inc.
Target Recruit Count
142318
Registration Number
NCT05611632
Locations
🇬🇧

EMS Healthcare Ltd, Chester, United Kingdom

REFLECTION: A Clinical Practice Learning Program for Galleri®

Recruiting
Conditions
Cancer
Early Detection of Cancer
First Posted Date
2022-01-25
Last Posted Date
2024-05-20
Lead Sponsor
GRAIL, Inc.
Target Recruit Count
17000
Registration Number
NCT05205967
Locations
🇺🇸

Vincere Cancer Center, Scottsdale, Arizona, United States

🇺🇸

Providence, Portland, Oregon, United States

🇺🇸

Providence, St. Jude, Fullerton, California, United States

and more 13 locations

PATHFINDER 2: a Multi-Cancer Early Detection Study

Not Applicable
Active, not recruiting
Conditions
Cancer
Early Detection of Cancer
First Posted Date
2021-12-13
Last Posted Date
2024-12-30
Lead Sponsor
GRAIL, Inc.
Target Recruit Count
35885
Registration Number
NCT05155605
Locations
🇺🇸

Sutter Health, Sacramento, California, United States

🇺🇸

HOAG Irvine, Irvine, California, United States

🇺🇸

HOAG Vivante Newport Mesa, Irvine, California, United States

and more 48 locations
  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.